Full Text View
Tabular View
No Study Results Posted
Related Studies
Bosentan in Treatment of Pulmonary Arterial Hypertension
This study has been completed.
Study NCT00266162   Information provided by Competence Network for Congenital Heart Defects
First Received: December 15, 2005   Last Updated: May 6, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Eisenmenger Syndrome
Additional conditions recognized in this trial
Eisenmenger Complex
Hypertension
Hypertension, Pulmonary
Syndrome
More general conditions related to this trial
Cardiovascular Abnormalities
Cardiovascular Diseases
Congenital Abnormalities
Disease
Heart Defects, Congenital
Heart Diseases
Lung Diseases
Pathologic Processes
Respiratory Tract Diseases
Vascular Diseases
Interventions listed in this trial
Bosentan administration
Additional drug interventions recognized in this trial
Bosentan
More general drug interventions related to this trial
Antihypertensive Agents
Cardiovascular Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Competence Network for Congenital Heart Defects
German Federal Ministry of Education and Research
Actelion


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services